These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 4995922

  • 21. An in vitro steroid sensitivity test: antibody-dependent cellular cytotoxicity (ADCC) reaction of peripheral lymphocytes in children with nephrotic syndrome.
    Petri I, László A, Bodrogi T.
    Acta Paediatr Hung; 1985; 26(3):247-53. PubMed ID: 4084413
    [Abstract] [Full Text] [Related]

  • 22. "Immunosuppressive" treatment of "chronic glomerulonephritis".
    Kallen RJ, Lewis EJ.
    J Pediatr; 1973 Feb; 82(2):335-9. PubMed ID: 4567554
    [No Abstract] [Full Text] [Related]

  • 23. Incidence & significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood.
    Bhuyan UN, Srivastava RN.
    Indian J Med Res; 1987 Jul; 86():53-60. PubMed ID: 3692560
    [No Abstract] [Full Text] [Related]

  • 24. [Immunological studies of the mechanism of the therapeutic action of azathioprine and of indomethacin in chronic active glomerulonephritis and the nephrotic syndrome].
    Campanacci L, Castellani A, Gambari PF, Huber W, Fagiolo U, Vesco F, Contini MG, Rebecca L.
    Minerva Nefrol; 1970 Jul; 17(4):127-50. PubMed ID: 4102147
    [No Abstract] [Full Text] [Related]

  • 25. [T- and B lymphocytes in lipoid nephrosis and various nephrotic syndromes in children].
    Zwolińska D.
    Pol Tyg Lek; 1987 Aug 24; 42(34):1035-9. PubMed ID: 3501113
    [No Abstract] [Full Text] [Related]

  • 26. [Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
    Olbing H.
    Dtsch Med Wochenschr; 1973 May 25; 98(21):1079-85. PubMed ID: 4196141
    [No Abstract] [Full Text] [Related]

  • 27. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
    Forese S, Tamborino G, Genova R.
    Minerva Pediatr; 1977 Mar 10; 29(8):547-50. PubMed ID: 865435
    [No Abstract] [Full Text] [Related]

  • 28. [Idiopathic nephrotic syndrome].
    Belovezhdov N.
    Vutr Boles; 1984 Mar 10; 23(4):14-21. PubMed ID: 6390968
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen.
    Soyka LF.
    Am J Dis Child; 1967 Jun 10; 113(6):693-701. PubMed ID: 6025079
    [No Abstract] [Full Text] [Related]

  • 30. [Current therapy of nephrotic syndrome].
    Wegmüller E.
    Schweiz Med Wochenschr; 1984 Mar 17; 114(11):374-80. PubMed ID: 6710108
    [Abstract] [Full Text] [Related]

  • 31. [Experience with immunosuppressive therapy in 13 children with kidney diseases].
    Dibelková M, Misarová Z, Holotová J.
    Cesk Pediatr; 1970 May 17; 25(5):213-6. PubMed ID: 5443743
    [No Abstract] [Full Text] [Related]

  • 32. Management of the idiopathic nephrotic syndrome.
    Glassock RJ.
    Contrib Nephrol; 1980 May 17; 23():158-80. PubMed ID: 7002448
    [No Abstract] [Full Text] [Related]

  • 33. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV.
    Vrach Delo; 1991 Feb 17; (2):51-3. PubMed ID: 2058123
    [Abstract] [Full Text] [Related]

  • 34. [Immunosuppressive treatment of corticoid resistant nephrotic syndrome in childhood].
    Boda D, Koltay M, Virág I.
    Monatsschr Kinderheilkd (1902); 1969 Feb 17; 117(2):48-52. PubMed ID: 5399049
    [No Abstract] [Full Text] [Related]

  • 35. [Complications of immunosuppresive therapy in chronic nephropathies in children].
    Sasinka M, Plenta I, Pavlovic M, Izakovic V, Kaiserová E, Páleníková O, Stubna J.
    Cesk Pediatr; 1976 Mar 17; 31(3):122-6. PubMed ID: 1269009
    [No Abstract] [Full Text] [Related]

  • 36. Immunosuppressive therapy.
    Winkelstein A, Segel D, Stolzer BL, Fogel M, Shadduck RK, Lewis M.
    Am J Med Sci; 1973 Feb 17; 265(2):92-108. PubMed ID: 4736193
    [No Abstract] [Full Text] [Related]

  • 37. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb 17; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 38. Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus.
    Fayaz A, Pirson Y, Cosyns JP, Yango J, Lambert M.
    Clin Nephrol; 2008 Apr 17; 69(4):290-3. PubMed ID: 18397704
    [Abstract] [Full Text] [Related]

  • 39. [The significance of predominant IgM deposition in glomerular diseases].
    Koshino Y, Kida H, Yokoyama H, Yoshimura M, Asamoto T, Saito Y, Tomosugi N, Abe T, Hattori N.
    Nihon Jinzo Gakkai Shi; 1984 Oct 17; 26(10):1293-300. PubMed ID: 6527428
    [No Abstract] [Full Text] [Related]

  • 40. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK, Cheng IK.
    Postgrad Med J; 1987 Sep 17; 63(743):757-9. PubMed ID: 3444800
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.